Trial Profile
Orexin receptor antagonism: An ascending multiple-dose study with almorexant
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Sep 2012
Price :
$35
*
At a glance
- Drugs Almorexant (Primary)
- Indications Insomnia
- Focus Pharmacodynamics
- Sponsors Actelion Pharmaceuticals
- 07 Sep 2012 New trial record